CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		132,214,695
Beginning balance at Dec. 31, 2022	$ 167,053	$ 14	$ 550,320	$ (4,530)	$ (378,751)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(20,259)				(20,259)
Issuance of Common Stock pursuant to equity compensation plan (in shares)		473,049
Shares withheld for tax withholdings on vested stock awards (in shares)		(170,415)
Shares withheld for tax withholdings on vested stock awards	(2,195)		(2,195)
Issuance of Class A Common Stock relating to employee stock purchase plan	2,034		2,034
Share-based compensation	3,577		3,577
Common Stock relating to asset acquisition (in shares)		109,625
Issuance of Class A Common Stock in connection with asset acquisition	1,310		1,310
Foreign currency translation adjustments	888			888
Ending balance (in shares) at Mar. 31, 2023		132,626,954
Ending balance at Mar. 31, 2023	$ 152,408	$ 14	555,046	(3,642)	(399,010)
Beginning balance (in shares) at Dec. 31, 2023	122,899,002	122,899,002
Beginning balance at Dec. 31, 2023	$ 59,390	$ 12	541,281	(3,036)	(478,867)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(679)				(679)
Issuance of Common Stock pursuant to equity compensation plan (in shares)		843,950
Shares withheld for tax withholdings on vested stock awards (in shares)		(289,533)
Shares withheld for tax withholdings on vested stock awards	(1,005)		(1,005)
Share-based compensation	6,636		6,636
Foreign currency translation adjustments	$ (1,047)			(1,047)
Ending balance (in shares) at Mar. 31, 2024	123,453,419	123,453,419
Ending balance at Mar. 31, 2024	$ 63,295	$ 12	$ 546,912	$ (4,083)	$ (479,546)